Notably, there was a distinctive positive correlation between the plasma GPC3 level in hepatocellular carcinoma patients and the concentration of IGF-1R which means targeting of GPC3/IGF-1 axis could be used to treat HCC. Here, GPC3 is linked to hepatocellular carcinoma.